LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study

BACKGROUND: Liver cancer is among the top five most common cancers globally. Lipid-lowering drugs such as statins can lower the risk of liver cancer, but may also cause liver damage. LipoCol Forte capsules (LFC), a red yeast rice product, have demonstrated significant antihypercholesterolemic effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Hsiang-Chun, Lin, Hung-Jen, Shih, Ying-Hsiu, Chou, Jen-Wei, Lin, Kuan-Wen, Jeng, Long-Bin, Huang, Sheng-Teng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237025/
https://www.ncbi.nlm.nih.gov/pubmed/37275448
http://dx.doi.org/10.4251/wjgo.v15.i5.828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237025/
https://www.ncbi.nlm.nih.gov/pubmed/37275448
http://dx.doi.org/10.4251/wjgo.v15.i5.828

Ejemplares similares